PapersPMID:32375340
Coenzyme Q10 Supplementation Improves Adipokine Levels and Alleviates Inflammation and Lipid Peroxidation in Conditions of Metabolic Syndrome: A Meta-Analysis of Randomized Controlled Trials.
What moved
1 findingHow to read these marks →- Decreases serum leptin
moderate
“Remarkably, a meta-analysis of included studies revealed significant reduction of leptin levels in individuals on CoQ10 supplementation when compared to those on placebo (SMD: −0.59 [95% CI: −0.98, −0.21]; I2 = 0%, p = 0.37).”
- Study
- meta-analysis
- Effect
- −0.59 standardised mean difference, 95% CI −0.98 to −0.21
- Population
- adults with metabolic syndrome; meta-analysis of 6 RCTs (318 participants)
Study record
- Design
- meta-analysis
- Species
- human
- Population
- adults with metabolic syndrome (mean age 48 years, 73% female; T2D n=176, NAFLD n=82, hypertension n=60), 6 RCTs
- Participants
- 318
- Comparator
- not stated in the paper
- Duration
- not reported
- Endpoints measured
- 6